Kureasia Pharma is a trusted name in global pharmaceutical exports, offering high-quality Dolutegravir 50mg + Lamivudine 300mg tablets for HIV treatment in Djibouti.
With increasing demand for reliable antiretroviral therapy across African regions, we ensure consistent access to WHO-compliant medicines backed by strong infrastructure and international logistics support.
About the Product
Dolutegravir 50mg + Lamivudine 300mg is a fixed-dose combination used in the treatment of HIV-1 infection. This dual therapy is widely recognized for its effectiveness, safety, and simplified dosing regimen.
- Dolutegravir: Integrase inhibitor that blocks viral replication
- Lamivudine: Reverse transcriptase inhibitor that reduces viral load
This combination helps improve patient adherence while maintaining strong clinical outcomes.
Our Global Pharmaceutical Export Services
As a leading exporter, Kureasia Pharma specializes in delivering medicines to Djibouti and other international markets with full regulatory and logistical support.
Key Services:
- Global pharmaceutical exports
- Regulatory documentation assistance
- Bulk supply and tender participation
- Reliable cold-chain and standard shipping
- Custom packaging and labeling as per country requirements
We understand the healthcare needs of Djibouti and ensure uninterrupted supply chains.
Infrastructure & Manufacturing Strength
Our advanced infrastructure ensures consistent quality and large-scale production:
- Contract Manufacturing: Flexible production capabilities for bulk requirements
- Automatic Bulk Counting & Filling System: Ensures accuracy, hygiene, and efficiency
- Modern production units aligned with international standards
Certifications & Quality Assurance
Kureasia Pharma follows strict global compliance protocols:
- WHO-GMP certified manufacturing
- International quality standards adherence
- Batch-wise testing and validation
- Export-ready documentation
We prioritize safety, efficacy, and reliability in every shipment.
Why Choose Kureasia Pharma for Djibouti?
- Strong experience in global pharmaceutical exports
- Competitive pricing for bulk orders
- Timely delivery across African markets
- Dedicated export support team
- Transparent and ethical business practices
Our goal is to support healthcare providers and distributors in Djibouti with dependable HIV treatment solutions.
Storage Guidelines
To maintain product quality:
- Store below 25°C
- Keep away from moisture and sunlight
- Use original packaging for safety
Frequently Asked Questions (FAQs)
What is Dolutegravir + Lamivudine used for?
It is used for the treatment of HIV-1 infection and helps reduce viral load while improving immune function.
Does Kureasia Pharma export to Djibouti?
Yes, Kureasia Pharma supplies pharmaceutical products to Djibouti with complete export documentation and logistics support.
Are your products certified?
All products are manufactured in WHO-GMP certified facilities and comply with international quality standards.
Can I order in bulk for hospitals or tenders?
Yes, we specialize in bulk supply and support government and private tenders globally.
📞 Contact Kureasia Pharma
Office Information:
- Phone: +91 95577 45784 / +91 93110 19560 / 011-40234824
- Email: sales@kureasiapharma.com
Registered Office:
B-255, Third Floor, Munshi Ram Gupta Marg,
Naraina Industrial Area Phase 1,
New Delhi – 110028, India
Manufacturing Unit:
Industrial Area, Plot Number-1,
Khasra No. 882, 883k, Village Salempur,
Mehdood-II, Haridwar – 249402, India
Looking for a reliable supplier of Dolutegravir 50mg + Lamivudine 300mg tablets in Djibouti?
Partner with Kureasia Pharma for high-quality medicines, competitive pricing, and seamless global export support.
👉 Contact us today to request a quote or discuss your bulk requirements.
Schedule a Free Consultation with Our Specialists
Let’s Discuss Your Requirements
Your Trusted Pharma Partner—From Formulation to Fulfillment
Join hands with Kureasia Pharma’s advanced production line for tablets, syrups, ointments, and more.
Copyright © 2026 Kureasia Pharma | Developed by OTD